Professional Documents
Culture Documents
Hypertensive Retinopathy
Hypertensive Retinopathy
Hypertensive Retinopathy
Pathophysiology
acute blood pressure elevation causes reversible
vasoconstriction in retinal blood vessels and
hypertensive crisis may cause optic disc oedema
(vasospastic response)
Prolonged and severe hypertension leads to
exudative vascular changes due to endothelial
damage and necrosis
Chronic (years) elevation of blood pressure
results in atherosclerosis through medial
hyperplasia and fibrosis, manifests as arteriole
wall thickening and arteriovenous nicking
(atherosclerotic response)
Types
1) Chronic or atherosclerotic retinopathy due to
chronic elevation of blood pressure
2) Acute or vasospastic retinopathy due to
acute elevation of blood pressure
Features
Features
Accelerated hypertension
Arteriolar macroaneurysms
Cotton wool spots or ischaemic areas swollen axonal endings caused by focal
ischaemia
Grade IV hypertensive
retinopathy is defined by the
presence of features of
grade III retinopathy plus
optic nerve head edema (eg,
the middle right panel).
Retinal arteriolar
narrowing due to
thickening and
opacification of arteriolar
walls (copper wiring)
caused by hypertensive
arteriosclerosis. Image
also shows macular
edema
Management
1) BP control - avoid rapid reduction of systemic
blood pressure as it can precipitate vascular
occlusion, pharmacological management
(antihypertensive)
2) If vision loss occurs,
Intravitreal injections of corticosteroids
antivascular endothelial growth factor
(ranibizumab)
Pathophysiology
Initial failure of normal retinal vascularisation
Followed by a phase of aggressive new vessel
formation extending forward into the vitreous
and causing traction detachment
Risk factors
Clinical features
Active ROP may progress
through 5 stages of increasing
severity
Spontaneous regression in
earlier stages occur without
intervention, but sequelae may
still cause visual loss
Signs:
1. New vessels
2. Development of retinal
haemorrhage
3. Increased tortuosity and dilation
of retinal vessels (poor
prognosis)
4. (severe) bleeding into vitreous
and retinal detachment, results
in blindness
The retina is divided into three zones, all centered on the optic nerve, to express
the location of the disease.
Zone I is defined as a diameter twice the distance between the fovea and the
center of the optic nerve. Clinically, this is approximately the area of the retina
seen through a 28D lens when the view is centered on the optic nerve.
Zone II is a circle that extends from the nasal ora serrata toward the temporal ora
serrata.
Zone III is a crescent encompassing the temporal area of the retina to the
temporal ora serrata that is not included in zone II.
The extent of the disease is defined in clock hours. Three oclock indicates the
nasal aspect of the right eye and the temporal aspect of the left eye.
In Stage 1 retinopathy
of prematurity, the
normal avascularized
retina appears to be
grayish and opaque in
color. A definite, flat,
demarcation line
between the
vascularized and
avascularized
characterizes this stage.
Screening
Recommended for babies born at or less than
31 weeks gestational age and low birthweight
< 1.5 kg
Dilated fundal examination is carried out
regularly from 6 or 7 weeks after birth until
nasal retina is fully vascularised
A more premature infants are screened more
intensively
Treatment
Treatment is indicated for threshold disease
(stage 3), by which the benefits of the
treatment outweigh the risks
Avascular area is ablated using either
cryotherapy or laser to induce regression of
abnormally growing new blood vessels
Pathophysiology
Sickle cell disease is due to point mutation in
the haemoglobin molecule in the RBCs in a
rigid and abnormally shaped RBCs, often
appeared as sickle-shaped.
Sickle-shaped RBCs will behave abnormally,
making them less flexible and unable to pass
freely through small blood vessels
Hypoxia exacerbates this tendency
Types
The most common and least severe:
haemoglobin S combined with haemoglobin A
(sickle trait)
Severe form: sickle cell haemoglobin C
diseases (SC disease) and sickle cell
haemoglobin with thalassaemia (SThal)
Confined retinopathy: homozygous sickle cell
disease (SS)
Clinical features
Systemic manifestations include anaemia and
sickle crises
Eye manifestations are divided into 2 types:
proliferative and non-proliferative
Eye manifestation
Proliferative retinopathy
Non-proliferative retinopathy
Vitreous haemorrhage
Venous tortuosity
Retinal tear
Salmon patch
and black
sunburst
retinal
haemorrhages
Multiple
dilated
vascular
segments
sea-fan
neovascularisation
Management
Screening for retinopathy at regular interval
for patients with sickle cell disease
Laser photocoagulation of neovascularisation
develops